Randomized human trial · Evidence assessment
Did glucosamine relieve knee pain in GAIT?
GAIT did not establish an overall pain benefit for glucosamine hydrochloride alone. Its exploratory combination-treatment subgroup is not proof that glucosamine alone works.
Longevity Lab Report · Assessed · Main study published 2006-02-23
Claim being examined
Glucosamine hydrochloride improves knee osteoarthritis pain more than placebo.
This page assesses the named study and relevant context. It is not a complete systematic review or an individual medical assessment.
What the study measured
- Population
- 1,583 people with symptomatic knee osteoarthritis.
- Study design
- Randomized, double-blind, five-group trial.
- What was tested
- Glucosamine hydrochloride, 1,500 mg daily; separate groups tested chondroitin, the combination, and celecoxib.
- Comparison
- Placebo; celecoxib was an active comparison.
- Duration
- 24 weeks.
- Measured outcome
- At least a 20% reduction in knee pain.
- Observed result
- 64.0% responded to glucosamine versus 60.1% to placebo: a 3.9 percentage-point difference, P=0.30. The combination also did not significantly outperform placebo overall.
- Safety limits
- Adverse events were generally mild and similarly distributed, but serious events occurred. This trial does not establish personal safety.
- Funding and disclosures
- NIH-funded; products were donated. Several authors disclosed relationships with pharmaceutical companies.
What limits the conclusion?
- The moderate-to-severe pain subgroup finding concerned the combination, not glucosamine alone.
- Hydrochloride and sulfate preparations should not be treated as identical interventions.
Prior and related evidence
An earlier three-year trial by Reginster and colleagues tested glucosamine sulfate in 212 patients and reported structural and symptom benefits. That product, duration and endpoint differ from GAIT.
The source list below distinguishes the main study from context.
What this evidence added
GAIT added a large placebo-controlled test of the hydrochloride preparation, with no significant overall benefit.
What it did not establish
A subgroup result does not replace the overall trial result; different formulations still need their own evidence.
Still unknown
- Whether an individual’s symptoms would respond.
- Whether other preparations reproduce the same result.
Does this study address your question?
Optionally compare the population, intervention and outcome. These are study comparisons, not medical advice or a treatment recommendation. Your answers stay on this page and are not saved or included in sharing.
Keep the evidence available
Open the public card to print or shareSaved in this browser only. No account or email required.
Assessment history
Sources
- GAIT (Clegg et al., 2006)
Main study · Published 2006-02-23 · Checked 2026-11-15 · DOI 10.1056/NEJMoa052771
Primary publication abstract and indexed results
- Glucosamine sulfate trial (Reginster et al., 2001)
Context · Published 2001-01-27 · Checked 2026-11-15 · PMID 11214126
Primary publication abstract and indexed results
Follow the research in the newsletter
Read the week’s longevity reporting and evidence assessments. Your watchlist and comparison answers are separate from your subscription.
Free. Unsubscribe anytime.
Every grade follows a published rubric. Sponsors do not influence findings or grades.